Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANEX: Tranexamic acid during excisional burn surgery
2024-513573-49-00Phase 4Completed
- Sponsor
- Maasstad Ziekenhuis
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in burn injury comparing Tranexamic acid with Placebo (0.9% sodium chloride) (2 arms). Primary endpoints: Volume of blood loss and Extent of fibrinolysis. Started Nov 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
burn injury
Beyond the preview
Go deeper on 2024-513573-49-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513573-49-00.